SIGNATUREFD, LLC - IOVANCE BIOTHERAPEUTICS INC ownership

IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 250 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.21 and the average weighting 0.1%.

Quarter-by-quarter ownership
SIGNATUREFD, LLC ownership history of IOVANCE BIOTHERAPEUTICS INC
ValueSharesWeighting
Q3 2023$11,129
+63.5%
2,446
+152.9%
0.00%
Q2 2023$6,808
+289.7%
967
+238.1%
0.00%
Q1 2023$1,747
+74.7%
286
+460.8%
0.00%
Q2 2022$1,000
-92.9%
51
-94.0%
0.00%
Q1 2022$14,000
+16.7%
847
+36.6%
0.00%
Q4 2021$12,000
-20.0%
620
+5.3%
0.00%
-100.0%
Q3 2021$15,000
+87.5%
589
+86.4%
0.00%
Q2 2021$8,000
+100.0%
316
+156.9%
0.00%
Q1 2021$4,000
+300.0%
123
+151.0%
0.00%
Q2 2020$1,000490.00%
Other shareholders
IOVANCE BIOTHERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Fairmount Funds Management LLC 565,890$26,257,0009.39%
Consonance Capital Management LP 1,710,803$79,381,0007.41%
GREAT POINT PARTNERS LLC 917,427$42,569,0006.91%
Avoro Capital Advisors LLC 7,500,000$348,000,0005.99%
Ghost Tree Capital, LLC 500,000$23,200,0005.17%
FRAZIER MANAGEMENT LLC 1,312,999$60,923,0004.69%
Perceptive Advisors 9,166,304$425,316,0004.56%
Ally Bridge Group (NY) LLC 360,000$16,704,0002.86%
Orbimed Advisors 6,645,100$308,333,0002.70%
ACUTA CAPITAL PARTNERS, LLC 164,800$7,647,0002.08%
View complete list of IOVANCE BIOTHERAPEUTICS INC shareholders